Lapatinib
98%
- Product Code: 202231
CAS:
231277-92-2
| Molecular Weight: | 581.06 g./mol | Molecular Formula: | C₂₉H₂₆ClFN₄O₄S |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD09264194 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20℃ |
Product Description:
Used in the treatment of HER2-positive breast cancer, particularly in patients who have already received other chemotherapy regimens. It works by inhibiting tyrosine kinases, including HER2 and EGFR, which are involved in cancer cell growth and survival. Often combined with other drugs like capecitabine to enhance effectiveness. Also studied in combination therapies for advanced or metastatic breast cancer to delay disease progression.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 250mg | 10-20 days | ฿1,150.00 |
+
-
|
| 1g | 10-20 days | ฿3,940.00 |
+
-
|
| 5g | 10-20 days | ฿15,000.00 |
+
-
|
| 25g | 10-20 days | ฿50,000.00 |
+
-
|
Lapatinib
Used in the treatment of HER2-positive breast cancer, particularly in patients who have already received other chemotherapy regimens. It works by inhibiting tyrosine kinases, including HER2 and EGFR, which are involved in cancer cell growth and survival. Often combined with other drugs like capecitabine to enhance effectiveness. Also studied in combination therapies for advanced or metastatic breast cancer to delay disease progression.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :